trending Market Intelligence /marketintelligence/en/news-insights/trending/RL3ShfUIaJhcq38WWICqZg2 content esgSubNav
In This List

Aclaris Therapeutics acquires privately held biotechnology company

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Aclaris Therapeutics acquires privately held biotechnology company

Aclaris Therapeutics Inc. acquired privately held biotechnology company Confluence Life Sciences Inc. for $10 million in cash and 350,000 shares of the company valued at $10 million.

Confluence is focused on the discovery and development of kinase inhibitors to treat inflammatory and immunological disorders and cancer.